Of note, CYP3A4 plays a key role in metabolic clearance of Nifedipine and Amlodipine in humans, which were commonly prescribed calcium channel blocker for the treatment of hypertension (Zhu et al., 2014; Wang X.F. et al., 2015). This evidence concerns the gene CYP3A4 and hypertensive disorder.